Microphysiological systems to elucidate the gut-brain axis biology of Parkinson’s disease
Parkinson’s disease is the second most common neurodegenerative disease and progressively limits fine motor control. Recent focus has hinted the disease origin could lie at least partially in the gut. Adam’s work focuses on integrating aspects of gut-brain axis physiology into ABNEL’s cut and assemble microfluidic chip designs to contribute to a better scientific understanding of Parkinson’s disease.
Adam joined ABNEL as a Chemical Engineering PhD student in September 2018. Prior, he did research on predicting the mixing of pharmaceutical systems using computational fluid dynamics (CFD). Adam also completed five internships (Johnson & Johnson [twice], Shamrock Technologies, Exxon Mobil, and Merck & Co) mainly in the healthcare/pharmaceutical industry supporting research, engineering, and commercialization.
B.S. Chemical Engineering
New Jersey Institute of Technology (NJIT) ‘18
Dr. Koppes was awarded a $500K NSF CAREER Award titled Defining the regulators of enteric plasticity in engineered microfluidic environments". A news article detailing the award can be found at the link below....
AIP published a commentary on a recent review paper led by Max A. Winkelman and Prof. Guohao Dai in collaboration with ABNEL and LNNR. More information can be found in the link below: https://aip.scitation.org/doi/10.1063/10.0003794 Original Publication:...